Official Website: 3Helix
source confidence: Medium status: Useful updated 2026-08-11
Summary
3Helix's official website describes a Salt Lake City biotechnology company that commercializes Collagen Hybridizing Peptide (CHP) reagents and platforms for research, histopathology, and collagen-damage applications. The site markets labeled CHP products for research use and references BASF's NeoHelix Regenerate personal-care launch.
Useful Claims
- Headquartered in Salt Lake City, Utah (terms list 675 Arapeen Dr; storefront footer lists 650 Komas Dr). This capture does not state a founding year.
- Company address listed in site terms: 675 Arapeen Dr, Ste. 302, Salt Lake City, UT 84108.
- CHP technology binds specifically to damaged/denatured collagen rather than intact triple-helix collagen.
- Product catalog includes research reagents such as B-CHP (biotin conjugate), F-CHP (5-FAM conjugate), R-CHP (Cy3 conjugate), and In Vivo sulfo-Cy7.5 conjugates, priced from roughly $218–$429 USD.
- Application pages cover histopathology, mechanical damage, collagen identification, and cell invasion.
- Site banner references BASF launching NeoHelix Regenerate based on CHP technology.
- About page mission: translate breakthrough science on damaged collagen into life-changing medicines; vision of treating diseases driven by extracellular biology.
- About page lists core team including CEO Mike Kirkness PhD, VP Toby Barrack MD MBA, and Operations lead Mallory Longacre MBA.
- Products are intended for internal research purposes unless separate commercial licensing is negotiated; terms prohibit diagnostic, therapeutic, or in vivo human use without authorization.
Verbatim
"The New Era of Collagen: BASF launches NeoHelix™ Regenerate. Read the press release." — Home page banner
"3HELIX Inc, 675 Arapeen Dr, Ste. 302, Salt Lake City, UT 84108." — Terms and conditions, definitions
"Internal Research Purposes: in vitro or in vivo use of the Products by a party, its employees, and/or its agents as an end user in connection with its own internal research, development or educational use and expressly excludes use for Commercial Purposes." — Terms and conditions, definitions
"From $218.00 USD" — Home page product catalog
"From $429.00 USD" — Home page product catalog
Reliability Notes
Official company source. Marketing claims about clinical impact, comparative efficacy, and therapeutic timelines are leads, not independent verification. BASF partnership details, Utah Innovation Fund participation, and founder history should be corroborated against press releases and third-party filings. Product pricing and catalog content may change without notice.